Rapid Discovery of Aspartyl Protease Inhibitors Using an Anchoring Approach
Markella Konstantinidou(University of California, San Francisco), Alexander Dömlingꝉ(University of Groningen), Varsha R. Jumde(University of Groningen), M. Yağız Ünver(University of Groningen), Fandi Sutanto(University of Groningen), Jörg Haupenthal(Helmholtz Centre for Infection Research), Anna K. H. Hirsch(University of Groningen), A. Heine(Philipps University of Marburg), F. Magari(Philipps University of Marburg), Carlos Jamie Camacho(University of Pittsburgh), G. Klebe(Lundbeck (Denmark))
Cited by 6
Related Papers
Covalent inhibitors: a rational approach to drug discovery
|RSC Medicinal Chemistry|2020|375
PROTACs– a game-changing technology
|Expert Opinion on Drug Discovery|2019|159
Molecular glues for protein-protein interactions: Progressing toward a new dream
|Cell chemical biology|2024|139
Immune Checkpoint PD‐1/PD‐L1: Is There Life Beyond Antibodies?
|Angewandte Chemie International Edition|2017|133
Inhibitors of programmed cell death 1 (PD-1): a patent review (2010-2015)
|Expert Opinion on Therapeutic Patents|2016|104